Back to search
FDAFDA · Food and drugs·Recall number D-0877-2026

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

Published October 7, 2026 · Recall initiated: September 23, 2026

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
PAROXETINE HYDROCHLORIDE
Manufacturer
Apotex Corp.
Distributor
US Nationwide.
UPC
0360505367436
Lot
Lot# TY9495, Exp Date: 05/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3 recalled?

Yes. FDA published recall D-0877-2026 on October 7, 2026. Reported hazard: Failed dissolution specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PAROXETINE HYDROCHLORIDE. UPC: 0360505367436.

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Recalert also tracks expiration dates so you can sell stock before it becomes a loss.

Check your inventory (free)